Major Pharmaceuticals: Levothyroxine Sodium Tablets, Usp, 125 Mcg (0.0125 Mg), 100 Tablets (10 X 10 Unit Dose Blisters) Per Carton
Summary Major Pharmaceuticals is recalling Levothyroxine Sodium 125 mcg tablets (NDC: 0904-6955-61) because the medication contains less active ingredient than it should, making it less effective. The affected tablets were distributed nationwide across all U.S. states and Washington, D.C. Anyone who filled a prescription for this specific product from Major Pharmaceuticals should be aware of this recall.
- Recalling firm
- Major Pharmaceuticals
- Product
- Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6955-61
- Reason
- Subpotent Drug
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-07-13
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide in the USA.
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/d433a0fe-6b33-4b12-92a7-28e8744be4ea